SUMMARY Synovia! effusions from 14 patients with rheumatoid arthritis contain factors capable of enhancing and suppressing the production of immunoglobulin when added to normal peripheral lymphocyte cultures in vitro. Utilizing a radioactive immune coprecipitation technique it could be demonstrated that enhancement was observed upon addition of relatively small amounts of synovial fluid, while addition of higher amounts resulted in suppression of immunoglobulin synthesis. Nine of ten non-rheumatoid joint effusions showed neither enhancing nor suppressing activities. The possible relationship of these events to lymphokine production in the joint is discussed.THE participation of immune mechanisms in the pathogenesis of rheumatoid arthritis (RA) is well established (Pekin et al., 1964;Smiley et al, 1968;Winchester et al, 1969;Rodman et al., 1967). Recently, we described the presence in rheumatoid synovial effusions of enhancing factors capable of stimulating immunoglobulin synthesis in peripheral-blood lymphocyte cultures in vitro (Rosenthal et al., 1976). The factors described are a low-molecular factor which elutes from an Agarose A 5m column with serum albumin, presumably a lymphokine, and a high-molecular factor, which elutes from such a column with an IgM marker, presumably an immune complex. The lowmolecular factor is non-specific and stimulates immunoglobulin synthesis in both rheumatoid and normal lymphocyte cultures. The high-molecular factor showed specificity in its exclusive stimulation of rheumatoid cells. Recently, evidence has accumulated that in the collaboration between T-B cells and macrophages, T cells not only have an enhancing effect on antibody response, but also have a suppressive effect on antibody formation (Baker et al., 1973;Hardin et al, 1973;Dutton, 1973;Herzenberg et al., 1973; SjSberg, 1972). The experiments presented here were designed to investigate the possibility that not only a B-cell enhancing function, but also B-cell suppression function is mediated by soluble factors. Such B-cell inhibitory factors may be produced in vivo by the inflamed synovium in rheumatoid arthritis and be present in the synovial effusion.
MATERIALS AND METHODSKnee-joint effusions from 14 patients with classical or definite rheumatoid arthritis (RA) as defined by the A.R.A. criteria (Ropes et al., 1959) and from 10 non-rheumatoid patients were obtained. The non-rheumatoid patients included six with osteoarthritis, two with ankylosing spondylitis, one with Reiter's syndrome and one with post-traumatic effusion.The effusions were immediately centrifuged at 2500 rev./min for 20 minutes at room temperature to remove cellular elements and the cell-free effusions treated with 0.02 mg of hyaluronidase/ml of joint fluid (bovine testes hyaluronidase, type I, Sigma Chem.